ADIL

Adial Pharmaceuticals, Inc - Common Stock (ADIL)

About Adial Pharmaceuticals, Inc - Common Stock (ADIL)

Adial Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment or prevention of addiction and related disorders. It offers the AD04, a selective serotonin-3 antagonist. The company was founded by Bankole A. Johnson and William B. Stilley, III in November 2010 and is headquartered in Glen Allen, VA.

Details

Daily high

$4.87

Daily low

$3.70

Price at open

$4.80

52 Week High

$10.75

52 Week Low

$1.31

Market cap

10.5M

Dividend yield

0.00%

Volume

99,985

Avg. volume

60,381

P/E ratio

-.48

Adial Pharmaceuticals, Inc - Common Stock News